MG Therapies


Public lists: Eye Health (703)

MG Therapies's delivers treatments for Dry Eye Syndrome and Meibomian Gland Dysfunction. The MGrx is an in-clinic table top device that delivers three clinical treatments (Lid Debridement, Gland Expression, Anti-inflammatory Cold Therapy).

MG Therapies's delivers treatments for Dry Eye Syndrome and Meibomian Gland Dysfunction. The MGrx is an in-clinic table top device that delivers three clinical treatments (Lid Debridement, Gland Expression, Anti-inflammatory Cold Therapy).

Company (Alive / Active)

All investors data 1 Investors

Phone:

Fax:



San Diego,
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MG Therapies $0M Jul 25, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MG Therapies Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Handheld thermal therapy device Aug 24, 2018 Application
System for providing interval thermal therapy Mar 23, 2017 Application